They reported that treated ovarian cancer patients are positive for intrachromosomal rearrangements involving the P-GP gene, placing it under the control of the promoter of strongly transcript genes, with SLC25A40 being the most consistently involved. The gene discussed is PGP; the disease is ovarian carcinoma.